Day 2 Track 2

Policy Considerations for Adopting and Expanding Telehealth at Your Cancer Program

Frank Micciche, Vice President, Public Policy and Communications, National Committee for Quality Assurance
Feyi Olopade Ayodele, MBA, Chief Executive Officer, Cancer IQ, Inc.
Mei Wa Kwong, JD, Executive Director, Center for Connected Health Policy
Teri Bedard, BA, RT(R)(T), CPC, Executive Director, Client and Corporate Resources, Revenue Cycle Coding Strategies (Moderator) 

This panel conversation will explore policy considerations for cancer programs looking to expand and sustain their telehealth services. Panelists will discuss reimbursement and regulatory barriers, lessons learned and opportunities in the current era, the status of provisions after the public health emergency ends, healthcare disparities, and the policies that are still required to ensure long-term adoption of telehealth.

Cancer Care During the Pandemic: The Good, the Bad, and the Ugly from the Patient Perspective

Elizabeth F. Franklin, PhD, MSW, Executive Director, Cancer Policy Institute, Cancer Support Community
Shelley Fuld Nasso, MPP, Chief Executive Officer, National Coalition for Cancer Survivorship
Michael Kolodziej, MD, Vice President and Chief Innovation Officer, ADVI Health (Moderator)

The rapid adoption of telehealth that enabled cancer programs to continue to care for patients during the pandemic is widely and extensively praised. But this acclaim is largely testimonial and anecdotal—and generally from providers. But what do patients think? What’s working in telehealth and what’s not? Is telehealth really going to become standard practice in the post-pandemic? The patient advocacy groups represented on this panel have studied telehealth from the patient perspective and will share their findings with the goal of improving patient care.

Video Visits to Virtual Care Centers: The Evolving Digital Opportunity 

Royce Cheng, Principal, The Chartis Group 
Kelley D. Simpson, MBA, Director, Chartis Oncology Solutions Leader, The Chartis Group

Gain information on virtual technologies and supporting digital tools with enduring value beyond the present pandemic, including ePROs, virtual care navigation, tumor boards, consultations, follow-up, and supportive care services. Learn reasons to support increased adoption of virtual care modalities, including the opportunity to dramatically expand care access beyond physical subspecialty hubs, promote screening in the face of significant declines in new cancer detection rates, and mitigate risks for patients.

Hear strategic drivers for adopting virtual care, such as improved resource efficiency and productivity, and clinical and research program growth through improved new patient consults and clinical trial access. Learn how to develop a virtual care center which serves as an operational hub for clinical expertise, service capabilities, and intellectual capital outside of traditional geographic constraints.

Keeping Patients Connected to Telegenetics—During and Beyond COVID-19

 
This session is sponsored by InformedDNA.

Mallory Kirby, Senior Analyst, The Advisory Board Company
Rachel McConachie, RN, BSN, Clinical Operations Director, Dignity Health Cancer Institute
Ashley Navarro, MS, LCGC, Board Certified Genetic Counselor (ABGC); Genetic Counseling Manger, Dignity Health Cancer Institute

Hear short- and long-term benefits of tele-genetic counseling, including expanded access, remote patient engagement, reduced administrative burden, and improved collaboration between genetic counselors and providers. Learn practical strategies to successfully implement a tele-genetic counseling program and integrate it into workflows. Understand how to leverage the Cancer IQ genetic cancer risk assessment platform to remotely screen patients for genetic cancers and deliver virtual genetic counseling sessions.